Results 31 to 40 of about 6,066 (161)
Recent Advances and Future Directions in the Understanding of Mucormycosis
Frontiers in Cellular and Infection Microbiology, 2022 Mucormycosis is an emerging infection caused by fungi of the order Mucorales that has recently gained public relevance due to the high incidence among COVID-19 patients in some countries.
Victoriano Garre
doaj +1 more source
Post-COVID-19-Invasive Pulmonary Mycosis
Libyan International Medical University Journal, 2022 COVID-19 has been associated with myriad manifestations as well as adverse outcomes. One of the less commonly reported consequences of COVID-19 is the occurrence of secondary infections in patients suffering acutely from COVID-19 or in those recuperating.
Satish Swain +9 more
doaj +1 more source
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
Diagnostics, 2022 A mucormycosis surge was reported during the COVID-19 pandemic in India. A literature search until 14 July 2022, with the aim of updating COVID-19-associated mucormycosis (CAM), identified 663 studies and 88 met inclusion criteria (8727 patients).
Maria Panagiota Almyroudi +4 more
doaj +1 more source
Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia
Journal of Medical Imaging and Radiation Oncology, EarlyView.ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes +2 more
wiley +1 more source
Chronic cutaneous and mucosal mucormycosis: Rhizopus arrhizus as a major pathogenic fungus
Emerging Microbes and InfectionsChronic cutaneous mucormycosis is a rare condition distinct from the acute form, characterized by a prolonged, indolent course and varied clinical presentations. This study presents a 5-year experience from a tertiary dermato-mycology clinic, identifying
Xingyu Li +11 more
doaj +1 more source
An Emergent Entity: Indolent Mucormycosis of the Paranasal Sinuses. A Multicenter Study
International Archives of Otorhinolaryngology, 2019 Introduction Indolent or chronic mucormycosis is a rare entity that affects both immunosuppressed and immunocompetent individuals. Additionally, its clinical evolution is nonspecific and there is no standardized treatment for this condition.
Erika Celis-Aguilar +11 more
doaj +1 more source
Frontiers in ImmunologyThis report outlines the case of a woman with rhino-orbital-cerebral mucormycosis following diabetic ketoacidosis, refractory to systemic and local antifungal treatment as well as repeated extensive sinonasal debridement.
Piremiya Thayanantham +5 more
doaj +1 more source
Animal Models to Study Mucormycosis
Journal of Fungi, 2019 Mucormycosis is a rare but often fatal or debilitating infection caused by a diverse group of fungi. Animal models have been crucial in advancing our knowledge of mechanisms influencing the pathogenesis of mucormycoses, and to evaluate therapeutic ...
Ilse D. Jacobsen
doaj +1 more source
Molecular Ecology Resources, Volume 26, Issue 3, April 2026.ABSTRACT High‐throughput sequencing of the Internal Transcribed Spacer (ITS) regions is the primary method for estimating fungal diversity from environmental DNA. However, reliance solely on ITS markers is complicated by its high variability in sequence length and the presence of multiple variants within a single genome, which can bias diversity ...
Vasilii Shapkin +11 more
wiley +1 more source
Recent Developments in the Diagnosis of Mucormycosis
Journal of Fungi, 2022 Mucormycosis is a potentially fatal infection that presents in different clinical forms and occurs in patients with various risk factors. Recently, the COVID-19 epidemic has been responsible for an increase in the incidence of mucormycosis, particularly ...
Eric Dannaoui
doaj +1 more source